European Stroke Organisation and European Society for Minimally Invasive Neurological Therapy guideline on acute management of basilar artery occlusion

ESO/ESMINT · 2024 · Europe

Source and licence

Authors
Daniel Strbian, Georgios Tsivgoulis, Johanna Ospel et al.
Title
European Stroke Organisation and European Society for Minimally Invasive Neurological Therapy guideline on acute management of basilar artery occlusion
Journal
European Stroke Journal, 2024
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC11569583

Licence statement of the original publication

This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

Open the original publication →Full text on Europe PMC

Recommendations

Verbatim, with grade of recommendation or strength of consensus where given.

PICO 1 for adults with BAO-related acute ischaemic stroke presenting within 24 h from the time last known well, does intravenous thrombolysis (IVT) alone compared to no IVT improve outcomes?

  • For adults with BAO-related acute ischaemic stroke presenting within 24 h from the time last known well, there are insufficient data to make an evidence-based recommendation on the use of IVT. Please see the Expert Consensus Statement below.Quality of evidence: -Strength of recommendation: -Expert consensus statement (10 voting members): 1. For adults with BAO-related acute ischaemic stroke presenting within 4.5 h from the time last known well without contraindications for IVT and without extensive ischemic changes in the posterior circulation*, 10/10 MWG members suggest intravenous thrombolysis rather than no intravenous thrombolysis (please also see PICO 5 and 7).2. For adults with BAO-related acute ischaemic stroke presenting between 4.5 and 12 h from the time last known well without contraindications for IVT (apart from the time window) and without extensive ischemic changes in the posterior circulation*, 8/10 MWG members suggest intravenous thrombolysis rather than no intravenous thrombolysis (please also see PICO 5 and 7).3. For adults with BAO-related acute ischaemic stroke presenting between 12 and 24 h from the time last known well without contraindications for IVT (apart from the time window) and without extensive ischemic changes in the posterior circulation*, 8/10 MWG members suggest intravenous thrombolysis rather than no intravenous thrombolysis (please also see PICO 5 and 7).*extensive bilateral and/or brainstem ischemic changes

PICO 5 For adults with BAO-related acute ischaemic stroke, does selection of reperfusion therapy (IVT and/or EVT) candidates based on a particular pc-ASPECTS compared with no specific threshold improve identification of patients with a therapy effect on outcomes?

  • For adults with BAO-related acute ischaemic stroke without extensive ischaemic changes at baseline (pc-ASPECTS 7–10), we suggest reperfusion therapy over no reperfusion therapy according to the certainty of evidence and strength of recommendation in PICOs 1, 2, 3, 4, and 7.For adults with BAO-related acute ischaemic stroke with pc-ASPECTS 0-6, there are insufficient data to make an evidence-based recommendation on the use of reperfusion therapy. (See the Expert Consensus Statement below).Quality of evidence: -Strength of recommendation: -Expert consensus statement (10 voting members): For adults with BAO-related acute ischaemic stroke with ischaemic changes at baseline being more extensive than those included in randomised controlled clinical trials (i.e. pc-ASPECTS 0-6), 10/10 MWG members suggest considering other prognostic variables (such as pre-stroke handicap, age, frailty) before offering reperfusion therapy.However, for patients with very extensive bilateral and/or brainstem ischemic lesions, 7/10 MWG members suggest no reperfusion therapy

PICO 6 for adults with BAO-related acute ischaemic stroke, does selection of reperfusion therapy (EVT or IVT) candidates based on advanced imaging criteria (perfusion, core, or collateral imaging) compared with no advanced imaging improve identification of patients with a therapy effect on outcomes?

  • For adults with BAO-related acute ischaemic stroke, there are insufficient data to make an evidence-based recommendation on the selection of reperfusion therapy based on evaluation of advanced imaging (perfusion, core, or collateral imaging). Please see the Expert Consensus Statement below.Quality of evidence: -Strength of recommendation: -Expert consensus statement (10 voting members): For adults with BAO-related acute ischaemic stroke (and in the absence of extensive ischaemic changes in the posterior circulation*), 10/10 MWG members suggest reperfusion therapy (EVT or IVT) rather than no reperfusion therapy, irrespective of any collateral score points.*extensive bilateral and/or brainstem ischemic changes

PICO 9 for adults with BAO-related acute ischaemic stroke and with suspected intracranial atherosclerotic disease (ICAD) and BA stenosis, does PTA and/or stenting of the basilar artery plus EVT compared with EVT alone improve outcomes?

  • For adults with BAO-related acute ischaemic stroke and with a suspected ICAD and BA stenosis, there is insufficient evidence to make an evidence-based recommendation on the use of PTA and/or stenting in addition to EVT. Please see the Expert Consensus Statement below.Quality of evidence: -Strength of recommendation: -Expert consensus statement (10 voting members): For adults with BAO-related acute ischaemic stroke and with suspected ICAD and severe underlying BA stenosis, 10/10 MWG members suggest rescue PTA and/or stenting after failed endovascular procedure (please also see PICO 10).

Abstract

The aim of the present European Stroke Organisation (ESO) guideline is to provide evidence-based recommendations on the acute management of patients with basilar artery occlusion (BAO). These guidelines were prepared following the Standard Operational Procedure of the ESO and according to the GRADE methodology. Although BAO accounts for only 1%–2% of all strokes, it has very poor natural outcome. We identified 10 relevant clinical situations and formulated the corresponding Population Intervention Comparator Outcomes (PICO) questions, based on which a systematic literature search and review was performed. The working group consisted of 10 voting members (five representing ESO and five ESMINT) and three non-voting junior members. The certainty of evidence was generally very low. In many PICOs, available data were scarce or lacking, hence, we provided expert consensus statements. First, we compared intravenous thrombolysis (IVT) to no IVT, but specific BAO-related data do not exist. Yet, historically, IVT was standard of care for BAO patients who were also included (albeit in small numbers) in IVT trials. Non-randomised studies of IVT-only cohorts showed high proportion of favourable outcomes. Expert Consensus suggests using IVT up to 24 h unless otherwise contraindicated. We further suggest IVT plus endovascular treatment (EVT) over direct EVT. EVT on top of best medical treatment (BMT) was compared to BMT alone within 6 and 6–24 h from last seen well. In both time windows, we observed a different effect of treatment depending on (a) the region where the patients were treated (Europe vs. Asia), (b) on the proportion of IVT in the BMT arm, and (c) on the initial stroke severity. In case of high proportion of IVT in the BMT group and in patients with NIHSS below 10, EVT plus BMT was not found better than BMT alone. Based on very low certainty of evidence, we suggest EVT + BMT over BMT alone (i.e. based on results of patients with at least 10 NIHSS points and a low proportion of IVT in BMT). For patients with an NIHSS below 10, we found no evidence to recommend EVT over BMT. In fact, BMT was non-significantly better and safer than EVT. Furthermore, we found a stronger treatment effect of EVT + BMT over BMT alone in proximal and middle locations of BAO compared to distal location. While recommendations for patients without extensive early ischaemic changes in the posterior fossa can, in general, follow those of other PICOs, we formulated an Expert Consensus Statement suggesting against reperfusion therapy in those with extensive bilateral and/or brainstem ischaemic changes. Another Expert Consensus suggests reperfusion therapy regardless of collateral scores. Based on limited evidence, we suggest direct aspiration over stent retriever as the first-line strategy of mechanical thrombectomy. As an Expert Consensus, we suggest rescue percutaneous transluminal angioplasty and/or stenting after a failed EVT procedure. Finally, based on very low certainty of evidence, we suggest add-on antithrombotic treatment during EVT or within 24 h after EVT in patients with no concomitant IVT and in whom EVT was complicated (defined as failed or imminent re-occlusion, or need for additional stenting or angioplasty).

Contents of the original publication

The section headings of the original.

  • Introduction
  • Methods
  • Composition and approval of the Module Working Group
  • Development and approval of clinical questions
  • Literature search
  • Data analysis
  • Evaluation of the quality of evidence and formulation of recommendations
  • Drafting of the document, revision and approval
  • Results
  • PICO 1
  • Analysis of current evidence
  • PICO 2
  • Analysis of current evidence
  • PICO 3
  • Analysis of current evidence
  • PICO 4
  • Analysis of current evidence
  • IVT versus no IVT depending on initial stroke severity
  • PICO 5
  • PICO 6
  • Analysis of current evidence
  • PICO 7
  • Analysis of current evidence
  • PICO 8
  • Analysis of current evidence
  • PICO 9
  • Analysis of current evidence
  • PICO 10
  • Analysis of current evidence
  • Discussion
  • Plain language summary

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint